Chancellor,Michael B

Institution: Chang Gung University College of Medicine, Taiwan

Top Collaborators: Chuang YC, Yoshimura N, Tyagi P, Wu M, Kaufman J, Kuo HC, Huang CC, Huang HY, Watanabe T, Inoue M, Sasaki K, Araki M, Uehara S, Monden K, Saika T, Nasu Y, Kumon H, Pruchnic R, Guan Z, Chung MS

Research Interests: Bladder, Muscle, Cells, Botulinum Toxin, Syndrome, Liposomes, Rats, Overactive Bladder, Hypersensitivity, Inflammation, Pge, Benign Prostatic Hyperplasia, Botulinum Toxin Type A, Gold, Hyperplasia, Injection, Lower Urinary Tract Symptoms, Prostate, Prostatic Hyperplasia, Treatment

Publications
Grants

Information and abstracts for author publications
Published Date	Impact	Publication
05/20/2008	8.5	European urology Intravesical botulinum toxin A administration inhibits COX-2 and EP4 expression and suppresses bladder hyperactivity in cyclophosphamide-induced cystitis in rats.	Abstract
01/04/2011	3.8	Seminars in reproductive medicine Stem cell therapy: a future treatment of stress urinary incontinence.	Abstract
06/18/2009	3.7	The Journal of urology Urodynamic and immunohistochemical evaluation of intravesical botulinum toxin A delivery using liposomes.	Abstract
04/30/2012	3.6	The journal of sexual medicine The presence of overactive bladder wet increased the risk and severity of erectile dysfunction in men with type 2 diabetes.	Abstract
04/26/2010	3	Neurourology and urodynamics Stem cell therapy for stress urinary incontinence.	Abstract
09/21/2010	3	Neurourology and urodynamics Intravesical immune suppression by liposomal tacrolimus in cyclophosphamide-induced inflammatory cystitis.	Abstract
11/16/2010	2.8	BJU international Expression of E-series prostaglandin (EP) receptors and urodynamic effects of an EP4 receptor antagonist on cyclophosphamide-induced overactive bladder in rats.	Abstract
02/01/2012	2.8	BJU international Botulinum toxin for the lower urinary tract.	Abstract
03/30/2009	2.8	BJU international Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis/painful bladder syndrome.	Abstract
09/30/2010	2.8	BJU international Nerve growth factor level in the prostatic fluid of patients with chronic prostatitis/chronic pelvic pain syndrome is correlated with symptom severity and response to treatment.	Abstract
08/27/2009	2.8	BJU international Multi-potent differentiation of human purified muscle-derived cells: potential for tissue regeneration.	Abstract
09/29/2009	2.8	BJU international Transabdominal ultrasonography of detrusor wall thickness in women with overactive bladder.	Abstract
07/07/2009	2.8	BJU international Instillation of liposomes vs dimethyl sulphoxide or pentosan polysulphate for reducing bladder hyperactivity.	Abstract
12/05/2008	2.6	Current opinion in urology Perspective of Botox for treatment of male lower urinary tract symptoms.	Abstract
08/13/2008	2.4	Urology In vitro and in vivo effect of lidocaine on rat muscle-derived cells for treatment of stress urinary incontinence.	Abstract

Grants Recieved by this author
Budget Start	Budget End	Grant Type	Project Cost	Project Title
9/01/2011	7/31/2014	NIH R01: Research Project	$1,014,852	Pharmacology of Intravesical Antisense Based Therapy for Over Active Bladder
6/15/2010	5/31/2014	NIH R01: Research Project	$603,010	Intravesical liposome drug delivery to treat interstitial cystitis